AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CETIRIZINE DIHYDROCHLORIDE BP
4 registrations across 3 African markets— 3 active
Markets with CETIRIZINE DIHYDROCHLORIDE BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CETRIZ SYRUP SYRUP | 🇷🇼Rwanda | LABORATORY & ALLIED LIMITED | active | Jul 2029 |
| ONCET 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ONCET ORAL SOLUTION Solution, Oral | 🇹🇿Tanzania | MEDLEY PHARMACEUTICALS LIMITED | active | — |
| Oncet Tablets | 🇹🇿Tanzania | Medley Pharmaceuticals Ltd | active | — |
CETIRIZINE DIHYDROCHLORIDE BP in Africa — Regulatory Overview
CETIRIZINE DIHYDROCHLORIDE BP is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Malawi, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.